Phenotype, hormonal profile and genotype of subjects with partial androgen insensitivity syndrome: report of a family with four adult males and one child with disorder of sexual differentiation

• Published in: Andrologia Vol. 41; no. 4; pp. 257 - 263
• Main Authors: Kulshreshtha, B., Philibert, P., Eunice, M., Audran, F., Paris, F., Khurana, M. L., Ammini, A. C., Charles, S.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.08.2009; Wiley-Blackwell
• Subjects: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase - genetics; 5 Alpha reductase; Adult; androgen insensitivity; Androgen-Insensitivity Syndrome - genetics; Biological and medical sciences; Genotype; Gynecology. Andrology. Obstetrics; Humans; Infant, Newborn; Male; Male genital diseases; Medical sciences; Phenotype; Receptors, Androgen - genetics; Sex Differentiation - genetics; Testosterone - blood; Endocrinopathy; Human; 5 Alpha reductase; phenotype; Enzyme; Pseudohermaphroditism; Sexual dysfunction; Male; Sexual differentiation disorder; androgen insensitivity; Congenital disease; Male genital system; Genital diseases; genotype; Target tissue resistance; Reproduction; Oxidoreductases; Child; Reductase
• ISSN: 0303-4569; 1439-0272
• DOI: 10.1111/j.1439-0272.2009.00921.x

Summary There is little information on the molecular basis of intrafamilial and inter‐familial phenotypic heterogeneity with the same androgen receptor (AR) mutation in patients with partial androgen insensitivity syndrome. A genetic analysis was performed in a large kindred with ambiguous genitalia and the genotype–phenotype correlations were analysed. The index case was brought for sex assignment. Family history revealed four other affected members who had hypospadias and varying degrees of virilisation. All the affected males had hemizygous mutations in the third exon of the AR gene (A596T). One was also found to have a heterozygous mutation in the fourth exon of the 5 alpha reductase type 2 gene (G196S). This affected male with double mutations was better virilised compared with the other affected members with a single mutation. The degree of virilisation correlated with serum testosterone levels. Gynaecomastia was not present in any of these subjects. It is concluded that the subject with dual gene defects also had higher levels of testosterone and pubertal virilsation. Testosterone levels possibly govern the degree of pubertal virilisation in subjects with A596T gene defects. It is not clear whether the better pubertal virilsation and higher testosterone are in any way causally related to the SRD5A2 gene defect.